Kansas hemp growers and processors warn that new federal restrictions targeting intoxicating hemp products threaten their investments and the state’s once-promising hemp industry. The upcoming changes could reshape rural economies and force businesses to rethink their strategy.

Trulieve has received conditional approval to cultivate, manufacture, and distribute medical cannabis in Texas — a major sign of the state’s expanding medical program. The move positions Texas for broader access, more competition, and a more sophisticated medical cannabis marketplace.

CMS has proposed new rules that could allow insurance coverage for CBD and other federally legal cannabinoid products. While this doesn’t open the door to THC yet, it signals a major shift toward integrating cannabinoids into mainstream healthcare.

Rumors are growing in Washington that a second Trump administration may aggressively pursue federal cannabis rescheduling. If it happens, it would reshape banking, insurance, taxes, and interstate commerce — transforming the entire cannabis industry.

Texas has expanded its medical cannabis program by adding new qualifying conditions and approving inhalable THC devices under prescription. This shift opens new opportunities for patients and businesses while signaling a broader modernization of Texas’ cannabis framework.

A new study found that Medicaid recipients living near multiple cannabis shops face higher rates of cannabis-use disorder and related hospitalizations. The research underscores the need for strong compliance, responsible retail practices, and community-driven education as the industry grows.

Virginia’s cannabis commission is preparing to unveil a long-awaited plan for adult-use retail, ending the gap between legalization and legal sales. The proposal eliminates local opt-outs, prioritizes small businesses, and reinvests revenue into communities most harmed by prohibition.

A St. Louis jury awarded $3 million to a cannabis consultant injured at a cultivation and manufacturing site, highlighting the growing legal exposure facing cannabis operators. The case underscores the urgent need for stronger workplace safety, documentation, and insurance protections across the industry.

Wisconsin hemp growers and processors are scrambling after federal legislation quietly banned many hemp-derived THC products. The move threatens major revenue streams and pushes the state’s hemp industry into emergency adaptation mode.

Brazil has approved Embrapa — the country’s premier agricultural research agency — to conduct long-term cannabis research, develop a national seed bank, and engineer industrial hemp varieties. The move positions Brazil as an emerging player in global cannabis science and future hemp export markets.

Rep. Dina Titus is demanding answers from the U.S. Attorney General after a DOJ memo signaled renewed enforcement on cannabis offenses. Her letter raises major concerns for state-legal operators who need clear federal guidance to protect their businesses and plan for the future.

A new federal amendment will ban hemp-derived THC products exceeding 0.4 mg THC per container, effectively eliminating the intoxicating hemp category. The rule will reshape the $28 billion hemp-THC industry and force businesses to prepare for major operational changes.

A federal funding bill signed by President Donald Trump includes language banning most hemp-derived THC beverages after November 2026. The move threatens the booming “cannabis drink” category and forces beverage companies to prepare now for reformulation, pivoting, or shutdown.

The New York Medical Cannabis Industry Association has filed a lawsuit against state regulators, claiming mismanagement allowed illicit cannabis to overrun the market. The case could force major changes in enforcement and reshape the state’s cannabis industry.

The Trump administration declined to file a government brief in a major Supreme Court cannabis case, signaling reduced federal engagement in shaping cannabis policy. The move highlights ongoing uncertainty at the federal level as courts, states, and agencies continue defining the future of cannabis regulation.

Rep. Nancy Mace has introduced draft legislation aimed at reversing the new federal ban on intoxicating hemp products. The proposal could offer major relief to the $28 billion hemp-THC sector, which was blindsided by the ban buried in the government-funding deal.

New York’s average cannabis price dropped from $38.61 to $32.15 as licensed store openings and expanded product selection increased competition. This decline shows the market is maturing — but it also raises new challenges for operators navigating shrinking margins and rising compliance pressure.

The new government-funding deal includes a provision limiting hemp-derived THC beverages to just 0.4 mg of THC per serving — effectively dismantling the booming low-dose beverage category. Companies that scaled in this space now face reformulation, revenue loss, and major regulatory challenges.

Texas avoided a state-level THC ban, but a new federal spending bill could outlaw most hemp-derived THC products nationwide. Industry leaders warn the move could devastate the multi-billion-dollar hemp sector and force thousands of operators to pivot or shut down.

A new federal spending bill includes language banning many synthetic cannabinoids, closing a loophole in the 2018 Farm Bill that enabled a booming intoxicating-hemp market. The move marks a major federal shift and will reshape hemp-THC businesses nationwide.